Hemodynamic basis for the limited renal injury in rats with angiotensin II-induced hypertension
- 1 February 2015
- journal article
- Published by American Physiological Society in American Journal of Physiology-Renal Physiology
- Vol. 308 (3) , F252-F260
Abstract
ANG II is thought to increase the susceptibility to hypertension-induced renal disease (HIRD) via blood pressure (BP)-dependent and BP-independent pathways; however, the quantitative relationships between BP and HIRD have not been examined in ANG II-infused hypertensive rats. We compared the relationship between radiotelemetrically measured BP and HIRD in Sprague-Dawley rats (Harlan) chronically administered ANG II (300–500 ng·kg−1·min−1, n = 19) for 4 wk versus another commonly employed pharmacological model of hypertension induced by the chronic administration of Nω-nitro-l-arginine methyl ester (l-NAME, 50 mg·kg−1·min−1, n = 23). Despite the significantly higher average systolic BP associated with ANG II (191.1 ± 3.2 mmHg) versus l-NAME (179.9 ± 2.5 mmHg) administration, the level of HIRD was very modest in the ANG II versus l-NAME model as evidenced by significantly less glomerular injury (6.6 ± 1.3% vs. 11.3 ± 1.5%, respectively), tubulointerstitial injury (0.3 ± 0.1 vs. 0.7 ± 0.1 injury score, respectively), proteinuria (66.3 ± 10.0 vs. 117.5 ± 10.1 mg/day, respectively), and serum creatinine levels (0.5 ± 0.04 vs. 0.9 ± 0.07 mg/dl, respectively). Given that HIRD severity is expected to be a function of renal microvascular BP transmission, BP-renal blood flow (RBF) relationships were examined in additional conscious rats administered ANG II ( n = 7) or l-NAME ( n = 8). Greater renal vasoconstriction was observed during ANG II versus l-NAME administration (41% vs. 23% decrease in RBF from baseline). Moreover, administration of ANG II, but not l-NAME, led to a unique BP-RBF pattern in which the most substantial decreases in RBF were observed during spontaneous increases in BP. We conclude that the hemodynamic effects of ANG II may mediate the strikingly low susceptibility to HIRD in the ANG II-infused model of hypertension in rats.Keywords
Funding Information
- Veterans Administration (1IK2BX001285)
- HHS | NIH | National Institute of Diabetes and Digestive and Kidney Diseases (NIDDK) (DK-40426, DK-61653)
- Veterans Administration (NEPH-014-99S)
This publication has 71 references indexed in Scilit:
- Large BP-dependent and -independent differences in susceptibility to nephropathy after nitric oxide inhibition in Sprague-Dawley rats from two major suppliersAmerican Journal of Physiology-Renal Physiology, 2012
- Involvement of glomerular renin−angiotensin system (RAS) activation in the development and progression of glomerular injuryClinical and Experimental Nephrology, 2011
- Renal protection in chronic kidney disease: hypoxia-inducible factor activation vs. angiotensin II blockadeAmerican Journal of Physiology-Renal Physiology, 2010
- Pentosan polysulfate treatment preserves renal autoregulation in ANG II-infused hypertensive rats via normalization of P2X1receptor activationAmerican Journal of Physiology-Renal Physiology, 2010
- Asymmetric dimethylarginine in angiotensin II-induced hypertensionAmerican Journal of Physiology-Regulatory, Integrative and Comparative Physiology, 2010
- Pressure-Induced Renal Injury in Angiotensin II Versus Norepinephrine-Induced Hypertensive RatsHypertension, 2009
- Protective Importance of the Myogenic Response in the Renal CirculationHypertension, 2009
- Unexpected effect of angiotensin AT1receptor blockade on tubuloglomerular feedback in early subtotal nephrectomyAmerican Journal of Physiology-Renal Physiology, 2009
- Exogenousl-Arginine Ameliorates Angiotensin II-Induced Hypertension and Renal Damage in RatsHypertension, 2008
- Renal autoregulation: new perspectives regarding the protective and regulatory roles of the underlying mechanismsAmerican Journal of Physiology-Regulatory, Integrative and Comparative Physiology, 2006